Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants.

INTRODUCTION

and Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma.

CASE PRESENTATION

We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest.

CLINICAL DISCUSSION

Cases of hematoma with severe COVID19 patients under anticoagulant therapy are reported in several case studies, particularly in geriatric population with the previous history of blood and/or cardiac disorders.

CONCLUSION

These patients should be carefully monitored for hematomas by skilled nurse and practitioner and timely treated and monitored.